Abstract
The reintroduction of thiocyanate in the treatment for arterial hypertension has, in recent years, attracted wide attention. A number of investigators have attested to its effectiveness in lowering both normal and abnormally elevated blood pressures.<sup>1</sup>On the other hand, it has been stated that in a large group, thiocyanate appears to exert no more beneficial effect on hypertension than do certain so-called nonspecific measures of therapy, classed under the general heading of "psychic and sedative treatment."<sup>2</sup>We have shown in a previous study<sup>3</sup>that thiocyanate administered in the dosage frequently recommended may be accompanied by serious toxic manifestations and even death. Furthermore, the great tendency toward variability of raised blood pressures<sup>4</sup>and the not infrequent spontaneous remissions observed in the course of essential hypertension<sup>5</sup>often render the true interpretation of any so-called therapeutic endeavor particularly hazardous. It therefore seemed advisable to us that another series
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
